Glimepiride
- Product NDC
- 68071-3024
- 11-digit product format
- 680713024
- Labeler code
- 68071
- Product ID
- 68071-3024_4a51cad8-ff11-4312-e054-00144ff88e88
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glimepiride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA202112
- Marketing category
- ANDA
- Marketing start
- 2015-07-14
- Marketing end
- 0000-00-00
- Substance
- GLIMEPIRIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-3024-3 | 2020-05-05 | C162847 | 48780-1 | 9d75b9d0-28e1-f424-e053-dadaa90a57ce | 4a51c3e8-76fe-684f-e054-00144ff8d46c |
| 68071-3024-6 | 2020-05-05 | C162847 | 48780-1 | 9d75b9d0-28e1-f424-e053-dadaa90a57ce | 4a51c3e8-76fe-684f-e054-00144ff8d46c |
| 68071-3024-8 | 2020-05-05 | C162847 | 48780-1 | 9d75b9d0-28e1-f424-e053-dadaa90a57ce | 4a51c3e8-76fe-684f-e054-00144ff8d46c |
| 68071-3024-9 | 2020-05-05 | C162847 | 48780-1 | 9d75b9d0-28e1-f424-e053-dadaa90a57ce | 4a51c3e8-76fe-684f-e054-00144ff8d46c |
| 68071-3024-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-28e1-f424-e053-dadaa90a57ce | 4a51c3e8-76fe-684f-e054-00144ff8d46c |
| 68071-3024-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-28e1-f424-e053-dadaa90a57ce | 4a51c3e8-76fe-684f-e054-00144ff8d46c |
| 68071-3024-8 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-28e1-f424-e053-dadaa90a57ce | 4a51c3e8-76fe-684f-e054-00144ff8d46c |
| 68071-3024-9 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-28e1-f424-e053-dadaa90a57ce | 4a51c3e8-76fe-684f-e054-00144ff8d46c |